Cargando…

Malignant Vascular Tumors of the Head and Neck—Which Type of Therapy Works Best?

SIMPLE SUMMARY: Malignant vascular tumors are extremely rare tumors with variable clinical courses, and few data on their clinical management are available. Diagnosis is difficult due to their wide morphologic appearance. The intent of the present review is to demonstrate the current knowledge and m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiegand, Susanne, Dietz, Andreas, Wichmann, Gunnar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699575/ https://www.ncbi.nlm.nih.gov/pubmed/34944821 http://dx.doi.org/10.3390/cancers13246201

Ejemplares similares

Perspectives of Induction With Chemo and/or Immune Check Point Inhibition in Head and Neck Organ Preservation Treatment
por: Wiegand, Susanne, et al.
Publicado: (2019)

Best Practice in Surgical Treatment of Malignant Head and Neck Tumors
por: Simon, Christian, et al.
Publicado: (2020)

Reduced Cytokine Release in Ex Vivo Response to Cilengitide and Cetuximab Is a Marker for Improved Survival of Head and Neck Cancer Patients
por: Cedra, Susan, et al.
Publicado: (2017)

Course of Self-Reported Dysphagia, Voice Impairment and Pain in Head and Neck Cancer Survivors
por: Zebralla, Veit, et al.
Publicado: (2021)

Association between malformation type, location and functional deficits in lymphatic malformations of the head and neck in children
por: Wiegand, Susanne, et al.
Publicado: (2023)

Efficacy of sirolimus in children with lymphatic malformations of the head and neck
por: Wiegand, S., et al.
Publicado: (2022)

Development of a Human Leukocyte Antigen Score to Predict Progression-Free Survival in Head and Neck Squamous Cell Carcinoma Patients
por: Wichmann, Gunnar, et al.
Publicado: (2018)

Frailty Assessed with FRAIL Scale and G8 Questionnaire Predicts Severe Postoperative Complications in Patients Receiving Major Head and Neck Surgery
por: Kunz, Viktor, et al.
Publicado: (2022)

Dysphagia, voice problems, and pain in head and neck cancer patients
por: Zebralla, Veit, et al.
Publicado: (2021)

Pre-Therapeutic VEGF Level in Plasma Is a Prognostic Bio-Marker in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Siemert, Julia, et al.
Publicado: (2021)

Head and neck cancer: effective prevention in youth and predictive diagnostics for personalised treatment strategies according to biological differences
por: Dietz, Andreas, et al.
Publicado: (2011)

Immune checkpoint blockade induced shifts in cytokine expression patterns in peripheral blood of head and neck cancer patients are linked to outcome
por: Röhl, Louisa, et al.
Publicado: (2023)

Obtaining Patient-Reported Outcomes Electronically With “OncoFunction” in Head and Neck Cancer Patients During Aftercare
por: Zebralla, Veit, et al.
Publicado: (2020)

Laryngeal Preservation Approaches: Considerations for New Selection Criteria Based on the DeLOS-II Trial
por: Dietz, Andreas, et al.
Publicado: (2019)

Cytokine Profiles of Head and Neck Squamous Cell Carcinoma Undergoing Dual Immunotherapy With Cetuximab and Pembrolizumab Identify Interferon Gamma-Induced Protein 10 as Novel Biomarker
por: Berszin, Michael, et al.
Publicado: (2022)

Discrimination of Head and Neck Squamous Cell Carcinoma Patients and Healthy Adults by 10-Color Flow Cytometry: Development of a Score Based on Leukocyte Subsets
por: Wichmann, Gunnar, et al.
Publicado: (2019)

Standardized Diagnostics Including PET-CT Imaging, Bilateral Tonsillectomy and Neck Dissection Followed by Risk-Adapted Post-Operative Treatment Favoring Radio-Chemotherapy Improve Survival of Neck Squamous Cell Carcinoma of Unknown Primary Patients
por: Wichmann, Gunnar, et al.
Publicado: (2021)

Choosing the Right Treatment Option for the Right R/M HNSCC Patient: Should We Adhere to PFE for First-Line Therapy?
por: Lübbers, Katharina, et al.
Publicado: (2021)

Screening for distress, related problems and perceived need for psycho-oncological support in head and neck squamous cell carcinoma (HNSCC) patients: a retrospective cohort study
por: Kunz, V., et al.
Publicado: (2021)

HPV Status as Prognostic Biomarker in Head and Neck Cancer—Which Method Fits the Best for Outcome Prediction?
por: Kühn, Jan Philipp, et al.
Publicado: (2021)

SATB1 as oncogenic driver and potential therapeutic target in head & neck squamous cell carcinoma (HNSCC)
por: Panchal, Omkar, et al.
Publicado: (2020)

Bayesian Networks to Support Decision-Making for Immune-Checkpoint Blockade in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Huehn, Marius, et al.
Publicado: (2021)

Standardized Diagnostic Workup and Patient-Centered Decision Making for Surgery and Neck Dissection Followed by Risk-Factor Adapted Adjuvant Therapy Improve Loco-Regional Control in Local Advanced Oral Squamous Cell Carcinoma
por: Wichmann, Gunnar, et al.
Publicado: (2021)

Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population
por: Hammermüller, C., et al.
Publicado: (2021)

Web-Based Patient-Reported Outcomes for ENT Patients—Evaluation of the Status Quo, Patients’ View, and Future Perspectives
por: Wald, Theresa, et al.
Publicado: (2022)

Malignant gastric outlet obstruction: Which is the best therapeutic option?
por: Troncone, Edoardo, et al.
Publicado: (2020)

Best Practice in Systemic Therapy for Head and Neck Squamous Cell Carcinoma
por: Oosting, Sjoukje F., et al.
Publicado: (2019)

Oral health in patients with different sites of head and neck squamous cell carcinoma is not different
por: Kanzow, Philipp, et al.
Publicado: (2023)

Malignant Peripheral Nerve Sheath Tumor of the Head and Neck Region
por: Han, Shengwei
Publicado: (2022)

From Basic Mechanisms to Clinical Research: Photodynamic Therapy Applications in Head and Neck Malignancies and Vascular Anomalies
por: Ramsay, Daniele, et al.
Publicado: (2021)

AB016. Which laser works best for benign prostatic hyperplasia?
por: Kim, Sae Woong
Publicado: (2015)

Which Choice of Delivery Model(s) Works Best to Deliver Fortified Foods?
por: Lalani, Baqir, et al.
Publicado: (2019)

Soft Tissue Special Issue: Perivascular and Vascular Tumors of the Head and Neck
por: Flucke, Uta, et al.
Publicado: (2020)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Epigenetic editing and tumor-dependent immunosuppressive signaling in head and neck malignancies
por: Gougousis, Spyridon, et al.
Publicado: (2022)

High-Risk Human Papillomavirus (HR-HPV) DNA Detection in Mouthwashes for Diagnosis of HPV-Driven Oropharynx Cancer and Its Curative Therapy—A Feasibility Study
por: Loermann, Gera, et al.
Publicado: (2022)

Which ultrasound transducer type is best for diagnosing pneumothorax?
por: Ketelaars, R., et al.
Publicado: (2018)

Signal averaging improves signal-to-noise in OCT images: But which approach works best, and when?
por: Baumann, Bernhard, et al.
Publicado: (2019)

Pain neuroscience education: Which pain neuroscience education metaphor worked best?
por: Louw, Adriaan, et al.
Publicado: (2019)

Dental therapy before and after radiotherapy–an evaluation on patients with head and neck malignancies
por: Sennhenn-Kirchner, Sabine, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ho2hra0n6b3g0h1bi6dl5u8uh1